Foot syndrome diabetic E10.70 oder E11.70

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 27.07.2021

Dieser Artikel auf Deutsch

Synonym(s)

DFS; diabetic foot

History
This section has been translated automatically.

Definition
This section has been translated automatically.

Complex of pathological symptoms localised on the feet, which are directly or indirectly considered to be the consequence of diabetes mellitus, which is usually a long-term condition. The symptoms in detail: bacterial and mycotic infections, pressure-related ulcerations (see Malum perforans) and/or destruction of deep tissue areas, severe neuropathic disorders of the foot up to complex osseous destruction (see Charcot arthropathy), complicated, diabetes-induced peripheral arterial circulatory disorders of varying degrees ( PAD).

Classification
This section has been translated automatically.

Classification according to Wagner:
  • Risk foot, no ulceration, possibly foot deformity
  • Superficial ulceration (usually due to improper footwear; see Malum perforans below)
  • Foot deformity
  • Deep ulcer to the joint capsule, tendons or bones
  • Deep ulcer with abscess, osteomyelitis or infection of the joint capsule
  • Limited necrosis in the forefoot or heel area
  • Necrosis of the entire foot.

Occurrence/Epidemiology
This section has been translated automatically.

4-10% of patients with diabetes mellitus suffer from DFS.

Etiopathogenesis
This section has been translated automatically.

Glycation (non-enzymatic glycosylation) leads to uncontrolled storage of glucose in numerous tissues, e.g. in vessels, nerves, connective tissue, etc..

The consequences are:

  • autonomic, motor and sensory nerve disorders (diabetogenic neuropathies)
  • Immunosuppression due to glycation of immunocompetent cells (especially macrophages, leukocytes)
  • Changes in the flow properties due to an increase in the viscosity of the blood
  • Macroangiopahies (carotid artery, large vessels of the legs: PAVK, typically below the knee).

Risk factors for diabetic foot syndrome are:

  • Long duration of diabetes:
  • High blood glucose levels
  • Hypercholesterolemia
  • Nicotine abuse
  • Presence of retinopathy, nephropathy or neuropathy
  • Decreased sensitivity
  • Callus formation due to incorrect stress (not painful or only less painful due to neuropathy)
  • Reduced muscle strength (limited stabilization of the foot)
  • Manifest leg ulcer or ulcer in the anamnesis
  • Arterial hypertension
  • Lack of exercise
  • CVI (chronic venous insufficiency with reduced joint mobility in the ankle joint - arthrogenic congestion syndrome)
  • Reduced joint mobility
  • Plantar hyperkeratosis
  • Unsuitable footwear.

Clinical features
This section has been translated automatically.

Initial: Warm, dry, red feet with reduced sensitivity, usually with pronounced callus formation at pressure points.

Progressive: Formation of polyneuropathic, painless ulcers on pressure-exposed areas of the foot (see below Acropathia ulcero-mutilans non-familiaris).

Late complications:

  • Infections: mycotic and bacterial infections of varying severity (erysipelas, gram-negative foot infection, foot phlegmon, necrotizing fasciitis, osteomyelitis).
  • Charcot arthropathy
  • Increasing disease-induced, enforced immobility of patients with its secondary symptoms.

Diagnosis
This section has been translated automatically.

Careful inspection of the feet: neuropathic, non-painful ulcers occurring at pressure points are the typical leading symptom of diabetic foot syndrome

Specific anamnesis

Examination of touch sensitivity

Foot pulses

Ankle-arm index

If necessary, radiological diagnostics: DSA or angio-MRI.

Therapy
This section has been translated automatically.

The therapy is based on several pillars:

  • Diabetes Optimization
  • Pressure relief
  • infection control (bacteriological monitoring, also gram-negative germs, e.g. Escherichia coli)
  • modern wound management with wound cleansing, if necessary necrosectomy
  • Consistent and situation-adapted therapy of the vascular disease.

Wound dressings with silver-activated charcoal overlays are recommended for wound treatment. Later, granulation of the wound can be promoted with a calcium-alginate dressing. Depending on the severity of the damage, minor amputations may be necessary. Education of the patient (wound and diabetes education).

Literature
This section has been translated automatically.

  1. Hertel T et al (2014) Diabetic foot syndrome. Skin14:190-195
  2. Cracks A (2014) The diabetic foot syndrome. Vasomed 26:191-196

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 27.07.2021